O-247 Molecular mechanisms of sensitivity and resistance to the HER1/EGFR-tyrosine kinase inhibitor erlotinib (Tarceva™)
- 1 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S72
- https://doi.org/10.1016/s0169-5002(03)91905-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: